Production (Stage)
biote Corp.
BTMD
$3.53
-$0.55-13.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.99M | 49.83M | 51.38M | 49.17M | 46.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.99M | 49.83M | 51.38M | 49.17M | 46.80M |
| Cost of Revenue | 12.61M | 14.30M | 15.17M | 15.29M | 13.45M |
| Gross Profit | 36.38M | 35.53M | 36.21M | 33.88M | 33.35M |
| SG&A Expenses | 26.69M | 30.30M | 23.15M | 24.92M | 22.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.30M | 44.60M | 38.32M | 40.21M | 36.38M |
| Operating Income | 9.69M | 5.23M | 13.06M | 8.96M | 10.43M |
| Income Before Tax | 17.46M | -1.22M | 15.86M | -10.30M | -3.32M |
| Income Tax Expenses | 1.62M | -4.70M | 3.20M | -11.00K | 2.40M |
| Earnings from Continuing Operations | 15.84M | 3.48M | 12.66M | -10.28M | -5.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.12M | 220.00K | -1.96M | 1.11M | 1.57M |
| Net Income | 13.72M | 3.70M | 10.70M | -9.18M | -4.16M |
| EBIT | 9.69M | 5.23M | 13.06M | 8.96M | 10.43M |
| EBITDA | 10.25M | 5.67M | 13.31M | 9.44M | 10.78M |
| EPS Basic | 0.44 | 0.12 | 0.34 | -0.28 | -0.12 |
| Normalized Basic EPS | 0.07 | 0.09 | 0.13 | 0.16 | 0.20 |
| EPS Diluted | 0.37 | 0.10 | 0.33 | -0.28 | -0.12 |
| Normalized Diluted EPS | 0.06 | 0.07 | 0.12 | 0.16 | 0.20 |
| Average Basic Shares Outstanding | 31.49M | 31.28M | 31.05M | 33.07M | 34.62M |
| Average Diluted Shares Outstanding | 36.95M | 37.29M | 32.26M | 33.07M | 34.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 4.23% | -44.89% | -1.99% |